Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease. - Wikidata - awgldk - TriplyDB

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

http://www.wikidata.org/entity/Q34309152

about

A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme Novel approaches to treat portal hypertension.Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection Management of varices in cirrhosis.New therapeutic paradigm for patients with cirrhosis.Future treatments of cirrhosis.Quantitative modeling of the physiology of ascites in portal hypertension.

P2860

Q24306614-5DF746AE-2DD7-4C75-9536-FB20CF83929E Q35020764-0F93796E-F359-4403-B898-3E076387C8BF Q35873829-A304C846-B698-4367-B4F9-A5E5F1B63980 Q36410515-2C8AA9D0-D498-424C-8C38-9C66FA929BFC Q37832507-6FFC1D2A-223B-46F8-8A49-3FD05FD70B9D Q38021413-313961FC-7FA9-4AEF-A4B6-83B72E2B169C Q38218607-D95CA59C-CAA7-4280-98D7-4E82E8B28FF1 Q43183668-82F7B43B-F737-402C-B2DD-36C41D5689F5

P2860

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

http://www.wikidata.org/entity/Q34309152

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@ast

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@en

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@nl

type

label

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@ast

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@en

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@nl

prefLabel

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@ast

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@en

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@nl

P1433

Q34309152-F5F37D04-DBC2-452A-AFAD-17732AF9A8EF

P1476

Q34309152-5CF51567-93F5-4DB6-93D6-985459E5D820

P2093

Q34309152-0AEF5120-23BD-46D3-B98D-E92F6BF1F1E9

Q34309152-2370D71C-1DC0-4DFB-8EEE-5A3B45E17DD1

Q34309152-2E11E44A-558A-4212-9B26-C1B1B6980EEE

Q34309152-8BCC4585-3C5C-45F1-B902-783F1479DC8F

P2860

Q34309152-060910CA-5B61-48FB-900E-073AAEA533C5

Q34309152-0A15B6E0-95BB-41B5-BED7-09166E2C18E6

Q34309152-189B53A0-C782-46B4-BAC7-33C04B930485

Q34309152-3EBC4BA6-29FF-451A-8411-4A98FCB62347

Q34309152-3FB00CF5-A85E-4B51-AC3F-01A9C80C3BEA

Q34309152-3FCB198B-4042-4F92-81DF-DA38E7524B31

Q34309152-4CAAAA61-5BE6-4783-8437-F305893031E4

Q34309152-58E57418-3976-4AAE-A9ED-4EDBC39E804B

Q34309152-59B40EB5-AB2C-4D3E-BBE3-67F4A2E47C8E

Q34309152-5AAED2B2-C813-471E-9ED8-8D3851333B49

P304

Q34309152-D3ABF85C-DED8-49C6-8C19-7E2333FDAA17

P31

Q34309152-58E76B0E-93AA-40EB-B7CD-53D91BA4BD55

P356

Q34309152-9BB8D2F8-B6AB-4034-9CA0-9AB42EA5AAB0

P407

Q34309152-62C0987E-D2B9-4161-A2DD-0C1A1391F891

P433

Q34309152-B35FDB37-D08F-41EB-B6BE-BD054A72E7B3

P478

Q34309152-3A194E25-FC64-4F4A-883F-D61DBB346010

P577

Q34309152-368759A3-20FD-4A95-9DBF-510ECF94B5B1

P5875

Q34309152-C7D25F23-D2CF-499D-B93C-6F7B4C9BC4CB

P698

Q34309152-75A1E3FA-651C-4F0F-B875-01E2DC96CB1F

P932

Q34309152-CFC6B022-A724-44FB-AEA0-80F2FF7AE42B

P356

P1433

P1476

Angiotensin converting enzyme ...... rapy in chronic liver disease.

@en

P2093

Burroughs AK

http://www.w3.org/2001/XMLSchema#string

Patch D

http://www.w3.org/2001/XMLSchema#string

Tang AK

http://www.w3.org/2001/XMLSchema#string

Vlachogiannakos J

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic stellate cells and the regulation of liver inflammation.

Angiotensin II receptor antagonists.

Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosis.

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.

Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension.

Clinical pharmacology of ACE inhibition.

The pericyte--a review.

Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.

The role of vasoactive mediators in portal hypertension.

P304

303-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.49.2.303

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277548044

http://www.w3.org/2001/XMLSchema#string

P698

11454810

http://www.w3.org/2001/XMLSchema#string

P932

1728379

http://www.w3.org/2001/XMLSchema#string